The growing interest in the rapid and sustained antidepressant effects of the dissociative
anesthetic ketamine and classic psychedelics, such as psilocybin, is remarkable. However …

In recent years, psychedelics have generated considerable excitement and interest as
potential novel therapeutics for an array of conditions, with the most advanced evidence …

Introduction There has been increasing interest in the role psilocybin may play in the
treatment of depressive disorders. Several clinical trials have shown psilocybin to have …

Background: The interest in psychedelics as a therapeutic intervention for existential distress
of people with terminal illness grounds on their mechanism of action and effect on the …

Objective: The authors critically examine the evidence base for psilocybin administered with
psychological support/therapy (PST) in the treatment of psychiatric disorders and offer …

Current pharmacological treatments for major depressive disorder (MDD) are often only
partially effective, with many patients experiencing no significant benefit, leading to …

Although several studies have well described the characteristics of people who use
psychedelics alongside their motivations and beliefs, little research has examined the …

It is impossible to ignore the rapidly growing interest in the therapeutic use of psychedelics.
Once marginalized as elements of counterculture, substances such as lysergic acid …

Simple Summary Psilocybin therapy shows promise for reducing anxiety and depression
and improving psychological well-being in cancer patients nearing the end of life. However …

Mood disorders, including depression, remain a significant global health concern,
necessitating continuous efforts to develop novel and more effective antidepressant …